All questionsDosing and administration: Rinvoq (upadacitinib) in rheumatoid arthritis5 questions · 2 sourcesTreatment combinationsCan RINVOQ be combined with other JAK inhibitors, biologic DMARDs, or potent immunosuppressants?“Limitations of Use: RINVOQ is not recommended for use in combination with other Janus kinase (JAK) inhibitors, biologic disease-modifying antirheumatic drugs (bDMARDs), or with potent immunosuppressants such as azathioprine and cyclosporine.” (opens the source at this quote in a new tab)CopyFlagDosingWhat is the RINVOQ dosage for rheumatoid arthritis?“RINVOQ is a 15 mg extended-release pill Take one pill 1 time a day with or without food Advise patients to avoid food or drink containing grapefruit during treatment with RINVOQ Swallow pill whole. Do not split, crush, or chew” (opens the source at this quote in a new tab)CopyFlagTaking treatmentWhat should be done if RINVOQ tablet residue appears in the stool?“Reports of medication residue in stool or ostomy output have occurred in patients taking RINVOQ. Most reports described anatomic or functional GI conditions with shortened GI transit times. Instruct patients to contact their healthcare provider if medication residue is observed repeatedly. Monitor patients clinically and consider alternative treatment if there is an inadequate therapeutic response.” (opens the source at this quote in a new tab)CopyFlagBefore treatmentBefore starting RINVOQ, which vaccines should patients get?“Prior to initiating RINVOQ, patients should be brought up to date on all immunizations, including prophylactic varicella zoster or herpes zoster vaccinations, in agreement with current immunization guidelines.” (opens the source at this quote in a new tab)CopyFlagCan RINVOQ patients receive live vaccines?“Avoid use of live vaccines during, or immediately prior to, RINVOQ therapy.” (opens the source at this quote in a new tab)CopyFlag